Literature DB >> 4207636

The vaccination of man and other animals against rabies.

J Crick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4207636      PMCID: PMC2495600          DOI: 10.1136/pgmj.49.574.551

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  74 in total

1.  ANTI-RABIES VACCINE OF TISSUE CULTURE ORIGIN.

Authors:  R E KISSLING; D R REESE
Journal:  J Immunol       Date:  1963-09       Impact factor: 5.422

2.  The use of commercially available vaccines for the oral vaccination of foxes against rabies.

Authors:  J G Debbie; M K Abelseth; G M Baer
Journal:  Am J Epidemiol       Date:  1972-09       Impact factor: 4.897

3.  Rabies vaccines and interferon.

Authors:  G S Turner
Journal:  J Hyg (Lond)       Date:  1972-09

Review 4.  Prevention of rabies in man.

Authors:  S A Plotkin; H F Clark
Journal:  J Infect Dis       Date:  1971-02       Impact factor: 5.226

Review 5.  Rabies vaccines.

Authors:  G S Turner
Journal:  Br Med Bull       Date:  1969-05       Impact factor: 4.291

6.  Inhibitory effect of passive antibody on active immunity induced against rabies by vaccination.

Authors:  T J Wiktor; R A Lerner; H Koprowski
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

7.  Two African viruses serologically and morphologically related to rabies virus.

Authors:  R E Shope; F A Murphy; A K Harrison; O R Causey; G E Kemp; D I Simpson; D L Moore
Journal:  J Virol       Date:  1970-11       Impact factor: 5.103

8.  Immunogenicity of concentrated and purified rabies vaccine of tissue culture origin.

Authors:  T J Wiktor; F Sokol; E Kuwert; H Koprowski
Journal:  Proc Soc Exp Biol Med       Date:  1969-07

9.  Human rabies after antiserum and vaccine postexposure treatment. Case report and review.

Authors:  J A Anderson; F T Daly; J C Kidd
Journal:  Ann Intern Med       Date:  1966-06       Impact factor: 25.391

10.  Study of antirabies immunization of man; observations with HEP Flury and other vaccines, with and without hyperimmune serum, in primary and recall immunizations.

Authors:  J P FOX; H KOPROWSKI; D P CONWELL; J BLACK; H M GELFAND
Journal:  Bull World Health Organ       Date:  1957       Impact factor: 9.408

View more
  9 in total

1.  Acquisition of spongiform encephalopathies in India through sheep-brain rabies vaccination.

Authors:  S C Arya
Journal:  Indian J Pediatr       Date:  1991 Sep-Oct       Impact factor: 1.967

2.  Controversies in viral immunization.

Authors:  M A Chernesky
Journal:  Can Fam Physician       Date:  1979-03       Impact factor: 3.275

3.  Rabies pathogenesis.

Authors:  F A Murphy
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

4.  Editorial: Rabies vaccination in man.

Authors: 
Journal:  Br Med J       Date:  1974-01-12

5.  Strains of rabies virus available for preparation of sylvatic rabies vaccines with special reference to vaccines prepared in cell culture.

Authors:  A J Rhodes
Journal:  Can Vet J       Date:  1981-08       Impact factor: 1.008

6.  Rabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination.

Authors:  Yongjun Wen; Hualei Wang; Hua Wu; Fuhe Yang; Ralph A Tripp; Robert J Hogan; Zhen F Fu
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

7.  Evaluation of phenotypic factors for anti-rabies antibody in vaccinated pet dogs.

Authors:  Bhumika F Savaliya; R A Mathakiya; B B Bhanderi; M K Jhala
Journal:  Virusdisease       Date:  2015-11-14

8.  Recognition of rabies and rabies-related viruses by T cells derived from human vaccine recipients.

Authors:  E Celis; D Ou; B Dietzschold; H Koprowski
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

9.  Interferon response to human diploid cell strain rabies vaccines in man.

Authors:  K G Nicholson; E K Kuwert; J Werner; P Harrison
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.